Canonical: https://ownershiptrace.com/13f/companies/1186

# Who owns MADRIGAL PHARMACEUTICALS, INC. (MDG)? Elite investor 13F holders

3 tracked elite investors reported holding MADRIGAL PHARMACEUTICALS, INC as of 2026-06-30, including Paulson & Co., Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Paulson & Co.](https://ownershiptrace.com/13f/investors/142) | MADRIGAL PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 719523739.00 USD | 1340020.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1035674/0001013594-26-000913-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | MADRIGAL PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 24668557.00 USD | 45942.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | MADRIGAL PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 18831374.00 USD | 35071.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | MADRIGAL PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | MADRIGAL PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)